Basic & Clinical Medicine ›› 2015, Vol. 35 ›› Issue (11): 1503-1507.

Previous Articles     Next Articles

SULT2B1 interference inhibits the epithelial-mesenchymal transition of human hepatocellular carcinoma BEL-7402 cells

  

  • Received:2015-04-28 Revised:2015-07-01 Online:2015-11-05 Published:2015-11-03
  • Contact: Xiao-Ming YANG E-mail:yxming1999@163.com

Abstract: Objective To investigate the relationship of hydroxysteroid sulfotransferase 2B1 (SULT2B1) and epithelial-mesenchymal transition (EMT), exploring its possible mechanisms. Methods cells were divided into three groups: control group, negative control siRNA group and SULT2B1-siRNA group. LipofectamineTM 2000 was employed for transient transfection. The SULT2B1 interference efficiency in treated BEL-7402 cells was detected by real-time PCR and western blot assays respectively. The protein levels of zonula occludens-1 (ZO-1), vimentin and transcriptional factor ZEB1 in BEL-7402 cells with SULT2B1 interference were determined by western blot analysis. Results The mRNA and protein levels of SULT2B1 in treated BEL-7402 cells were decreased significantly as compared with the negative control group (P< 0.05). The protein level of ZO-1 was up-regulated significantly (P<0.05), while vimentin and the transcriptional factor ZEB1 were decreased in BEL-7402 cells with SULT2B1 interference (P<0.05),. Conclusion SULT2B1 interference can inhibit the epithelial-mesenchymal transition of BEL-7402 cells by down-regulating transcriptional factor ZEB1.

Key words: Key words: hepatocellular carcinoma, hydroxysteroid sulfotransferases 2B1, epithelial- mesenchymal transition, ZEB1

CLC Number: